$69.59
Price
$9.7B
Market Cap
—
P/E Ratio
-15.9
Forward P/E
$-0.01
EPS (TTM)
—
Dividend Yield
$917M
Cash
$366M
Total Debt
139M
Shares Out
$9.57
$76.76
52-Week Range
Institutional Ownership of ARROWHEAD PHARMACEUTICALS IN
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for ARROWHEAD PHARMACEUTICALS IN
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| No activity found for this stock. | |||||
Insider Trading for ARROWHEAD PHARMACEUTICALS IN
6 Months Insider Sentiment
Buy $0
Sell $35.1M
0
Buys
58
Sells
-35.1M
Net
14
Grants
Largest
$6.9M
Anzalone
$2.9M
Anzalone
$2.4M
Anzalone
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jan 06, 2026 | Patrick O'Brien | COO | GRANT | 540 | — | — |
| Jan 06, 2026 | James C Hamilton | Chief Medical Officer | GRANT | 75.0K | — | — |
| Jan 06, 2026 | Daniel Joseph Apel | Chief Financial Officer | GRANT | 75.0K | — | — |
| Jan 06, 2026 | Patrick O'Brien | COO | GRANT | 440 | — | — |
| Jan 06, 2026 | Patrick O'Brien | COO | GRANT | 75.0K | — | — |
| Jan 05, 2026 | Patrick O'Brien | COO | SELL | 2.3K | $64.04 | $150K |
| Jan 05, 2026 | Patrick O'Brien | COO | SELL | 2.7K | $64.44 | $174K |
| Jan 05, 2026 | Patrick O'Brien | COO | SELL | 4.4K | $61.20 | $267K |
| Jan 05, 2026 | Patrick O'Brien | COO | SELL | 5.9K | $62.91 | $369K |
| Jan 05, 2026 | Patrick O'Brien | COO | SELL | 6.2K | $62.23 | $384K |
| Jan 05, 2026 | Patrick O'Brien | COO | SELL | 11.8K | $63.84 | $756K |
| Jan 05, 2026 | Patrick O'Brien | COO | SELL | 13.5K | $62.96 | $847K |
| Jan 05, 2026 | James C Hamilton | Chief Medical Officer | SELL | 14.8K | $63.01 | $932K |
| Jan 05, 2026 | James C Hamilton | Chief Medical Officer | SELL | 12.7K | $63.95 | $813K |
| Jan 05, 2026 | James C Hamilton | Chief Medical Officer | SELL | 6.1K | $62.28 | $379K |
| Jan 05, 2026 | James C Hamilton | Chief Medical Officer | SELL | 4.6K | $61.24 | $283K |
| Jan 05, 2026 | James C Hamilton | Chief Medical Officer | SELL | 1.2K | $64.49 | $77K |
| Jan 05, 2026 | James C Hamilton | Chief Medical Officer | SELL | 437 | $65.97 | $29K |
| Jan 05, 2026 | James C Hamilton | Chief Medical Officer | SELL | 309 | $68.00 | $21K |
| Jan 05, 2026 | Patrick O'Brien | COO | SELL | 46 | $68.00 | $3K |
| Jan 05, 2026 | Patrick O'Brien | COO | SELL | 313 | $68.00 | $21K |
| Jan 05, 2026 | Patrick O'Brien | COO | SELL | 600 | $61.12 | $37K |
| Jan 05, 2026 | Patrick O'Brien | COO | SELL | 900 | $66.01 | $59K |
| Jan 02, 2026 | Christopher Richard Anzalone | Chief Executive Officer | SELL | 5.8K | $66.39 | $383K |
| Jan 02, 2026 | Christopher Richard Anzalone | Chief Executive Officer | SELL | 7.4K | $65.88 | $489K |
| Dec 31, 2025 | Patrick O'Brien | COO | GRANT | 560 | — | — |
| Dec 29, 2025 | Christopher Richard Anzalone | Chief Executive Officer | SELL | 35.2K | $69.33 | $2.4M |
| Dec 29, 2025 | Christopher Richard Anzalone | Chief Executive Officer | EXERCISE | 16.5K | $6.15 | $102K |
| Dec 29, 2025 | Christopher Richard Anzalone | Chief Executive Officer | EXERCISE | 35.2K | $6.15 | $216K |
| Dec 29, 2025 | Christopher Richard Anzalone | Chief Executive Officer | SELL | 16.5K | $68.69 | $1.1M |
| Dec 26, 2025 | Mauro Ferrari | Director | SELL | 7.5K | $70.00 | $527K |
| Dec 22, 2025 | Christopher Richard Anzalone | Chief Executive Officer | SELL | 2.6K | $68.85 | $177K |
| Dec 22, 2025 | Christopher Richard Anzalone | Chief Executive Officer | SELL | 10.0K | $68.33 | $684K |
| Dec 19, 2025 | William D. Waddill | Director | SELL | 5.5K | $68.01 | $371K |
| Dec 19, 2025 | Victoria Vakiener | Director | SELL | 2.8K | $66.63 | $186K |
| Dec 19, 2025 | Victoria Vakiener | Director | SELL | 2.0K | $68.39 | $134K |
| Dec 19, 2025 | Christopher Richard Anzalone | Chief Executive Officer | SELL | 8.1K | $68.01 | $554K |
| Dec 19, 2025 | Christopher Richard Anzalone | Chief Executive Officer | SELL | 4.0K | $66.67 | $265K |
| Dec 19, 2025 | Christopher Richard Anzalone | Chief Executive Officer | SELL | 1.3K | $68.48 | $90K |
| Dec 19, 2025 | William D. Waddill | Director | SELL | 500 | $68.53 | $34K |
| Dec 19, 2025 | Adeoye Y Olukotun | Director | SELL | 6.1K | $68.04 | $414K |
| Dec 19, 2025 | Adeoye Y Olukotun | Director | SELL | 3.1K | $66.70 | $206K |
| Dec 19, 2025 | Adeoye Y Olukotun | Director | SELL | 827 | $68.48 | $57K |
| Dec 19, 2025 | Victoria Vakiener | Director | SELL | 5.3K | $67.97 | $359K |
| Dec 19, 2025 | William D. Waddill | Director | SELL | 2.4K | $66.66 | $161K |
| Dec 17, 2025 | Christopher Richard Anzalone | Chief Executive Officer | SELL | 35.8K | $64.51 | $2.3M |
| Dec 17, 2025 | Christopher Richard Anzalone | Chief Executive Officer | SELL | 2.0K | $66.30 | $131K |
| Dec 17, 2025 | Christopher Richard Anzalone | Chief Executive Officer | SELL | 982 | $65.53 | $64K |
| Dec 17, 2025 | Christopher Richard Anzalone | Chief Executive Officer | SELL | 46.3K | $63.55 | $2.9M |
| Dec 16, 2025 | Christopher Richard Anzalone | Chief Executive Officer | SELL | 1.0K | $64.96 | $65K |
| Dec 16, 2025 | Christopher Richard Anzalone | Chief Executive Officer | SELL | 166 | $66.77 | $11K |
| Dec 16, 2025 | Adeoye Y Olukotun | Director | GRANT | 7.8K | — | — |
| Dec 16, 2025 | Christopher Richard Anzalone | Chief Executive Officer | SELL | 1.3K | $65.77 | $86K |
| Dec 16, 2025 | Christopher Richard Anzalone | Chief Executive Officer | SELL | 3.2K | $67.87 | $219K |
| Dec 16, 2025 | Christopher Richard Anzalone | Chief Executive Officer | SELL | 6.7K | $64.29 | $428K |
| Dec 16, 2025 | Christopher Richard Anzalone | Chief Executive Officer | SELL | 8.4K | $60.51 | $509K |
| Dec 16, 2025 | Christopher Richard Anzalone | Chief Executive Officer | SELL | 8.5K | $62.94 | $533K |
| Dec 16, 2025 | Christopher Richard Anzalone | Chief Executive Officer | SELL | 11.0K | $61.25 | $671K |
| Dec 16, 2025 | Christopher Richard Anzalone | Chief Executive Officer | SELL | 14.1K | $62.12 | $876K |
| Dec 16, 2025 | Douglas S Ingram | Director | GRANT | 7.8K | — | — |
| Dec 16, 2025 | Hongbo Lu | Director | GRANT | 7.8K | — | — |
| Dec 16, 2025 | Mauro Ferrari | Director | GRANT | 7.8K | — | — |
| Dec 16, 2025 | Michael S Perry | Director | GRANT | 7.8K | — | — |
| Dec 16, 2025 | Victoria Vakiener | Director | GRANT | 7.8K | — | — |
| Dec 16, 2025 | William D. Waddill | Director | GRANT | 7.8K | — | — |
| Dec 15, 2025 | Christopher Richard Anzalone | Chief Executive Officer | SELL | 8.1K | $69.96 | $570K |
| Dec 15, 2025 | Christopher Richard Anzalone | Chief Executive Officer | SELL | 21.3K | $69.28 | $1.5M |
| Dec 15, 2025 | Christopher Richard Anzalone | Chief Executive Officer | SELL | 100.5K | $68.67 | $6.9M |
| Dec 12, 2025 | Christopher Richard Anzalone | Chief Executive Officer | GRANT | 180.0K | — | — |
| Dec 05, 2025 | Michael S Perry | Director | SELL | 16.2K | $61.03 | $992K |
| Nov 28, 2025 | Mauro Ferrari | Director | SELL | 8.8K | $56.39 | $493K |
| Oct 01, 2025 | James C Hamilton | Chief Medical Officer | SELL | 20.0K | $35.00 | $700K |
| Sep 12, 2025 | James C Hamilton | Chief Medical Officer | SELL | 15.0K | $30.00 | $450K |
| Sep 02, 2025 | James C Hamilton | Chief Medical Officer | SELL | 15.0K | $25.00 | $375K |